Published: 13 August 2020
Author(s): Giorgio Gentile, Fabio Angeli, Gianpaolo Reboldi
Section: Commentary

Chronic kidney disease (CKD) affects 8-16% of the population worldwide and is a huge global health issue, given its strong association with higher cardiovascular morbidity and mortality, progression towards end-stage renal disease, and other complications including cognitive decline, mineral bone disease and anaemia [1]. Despite huge efforts to identify novel and more specific kidney biomarkers [2], estimation of glomerular filtration rate (GFR) remains the mainstay of initial CKD diagnosis, its staging, and its subsequent management.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.